News for Mustang Bio, Inc. (MBIO)

Singapore-based Basel Medical Group Ltd (BMGL) is up over 88 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Investorideas.com (www.investorideas.com) a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for M...

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 400 points on Monday. The Dow traded down 1% to 44,379.69 while the...

Mustang Bio (MBIO) shares soared 90% in premarket trading following FDA approval for orphan drug status of its CAR T-cell therapy. Wall Street analysts

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Monday. Following the market opening Monday, the Dow traded do...

In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded ...

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted stronger-than-expected results for the third quarter. The company posted quarterly earnings of $1.86 per share, beating market estimates of 98 cents per share.

California-based Liminatus Pharma, Inc. (LIMN) is up over 83 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Emrosiâ„¢ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired

Article Summary: Mustang Bio Inc. (MBIO) sells Worcester, MA facility to AbbVie for $1 million, aiming to save $2 million over the next two years. Analys

Summary: Mustang Bio, Inc. (MBIO) retains Nasdaq listing by meeting key compliance metrics. Wall Street analysts offer a bullish outlook with price targe

Shares of ServiceNow, Inc. NOW rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Serv...

**media[558457]**

Texas-based Interactive Strength Inc. (TRNR) is up over 30 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Mustang Bio (MBIO) stock plunged 29% post-market after the company announced it exited the lease for its manufacturing facility in Worcester, Mass. Read more here.

WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (”œMustang” or the ”œCompany”) ( MBIO), a clinical-stage biopharmaceutical company f

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction by acquiring 102,125.74 shares of Mustang Bio Inc (MBIO) at a pr

Mustang Bio (MBIO) said on Tuesday that it has received notice from The Nasdaq Stock Market about regaining compliance with the minimum bid price requirement.